Correction to: SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion

Bibliographic Details
Title: Correction to: SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion
Authors: Sarah Halford, Susan Wan, Ilaria Dragoni, Julie Silvester, Bobojon Nazarov, Daniel Anthony, Suzie Anthony, Emma Ladds, John Norrie, Kevin Dhaliwal, and the CDD SPIKE-1 Project Team
Source: Trials, Vol 23, Iss 1, Pp 1-1 (2022)
Publisher Information: BMC, 2022.
Publication Year: 2022
Collection: LCC:Medicine (General)
Subject Terms: Medicine (General), R5-920
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1745-6215
Relation: https://doaj.org/toc/1745-6215
DOI: 10.1186/s13063-022-06266-0
Access URL: https://doaj.org/article/b21f19e815dd45c1a5e94555ef323a1a
Accession Number: edsdoj.b21f19e815dd45c1a5e94555ef323a1a
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:17456215
DOI:10.1186/s13063-022-06266-0
Published in:Trials
Language:English